UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 342

Sortiert nach

Vancomycin: A History

Clinical infectious diseases, 2006-01, Vol.42 (Supplement-1), p.S5-S12

Levine, Donald P

2006

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1361-1364

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Clinical infectious diseases, 2011-02, Vol.52 (3), p.e18-e55

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

Clinical infectious diseases, 2011-02, Vol.52 (3), p.285-292

2011

Link zum Volltext

Verfügbarkeit prüfen

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2009-08, Vol.49 (3), p.325-327

2009

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

American journal of health-system pharmacy, 2009-01, Vol.66 (1), p.82-98

2009

Link zum Volltext

Verfügbarkeit prüfen

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic

Clinical infectious diseases, 2009-03, Vol.48 (6), p.713-721

2009

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study

Pharmacotherapy, 2011-06, Vol.31 (6), p.527-536

2011

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4190-4196

2013

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin in the Treatment of Patients with Infective Endocarditis: Experience from a Registry

The American journal of medicine, 2007-10, Vol.120 (10), p.S28-S33

2007

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

American journal of health-system pharmacy, 2020-05, Vol.77 (11), p.835-864

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3731-3733

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Clinical infectious diseases, 2011-04, Vol.52 (8), p.975-981

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia

Antimicrobial Agents and Chemotherapy, 2007-12, Vol.51 (12), p.4249-4254

2007

Link zum Volltext

Verfügbarkeit prüfen

Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.2978-2985

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcome of patients with injection drug use–associated endocarditis admitted to an intensive care unit

Journal of critical care, 2010-06, Vol.25 (2), p.248-253

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting

Infectious diseases and therapy, 2018-12, Vol.7 (4), p.495-507

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Delayed Therapy in Serious Bacterial Infections: Role of Technology and the Clinician at the Bedside

The American journal of the medical sciences, 2019-03, Vol.357 (3), p.177-178

2019

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

The New England journal of medicine, 2006-08, Vol.355 (7), p.653-665

2006

Link zum Volltext

Verfügbarkeit prüfen

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2921-2926

2013

Link zum Volltext

Verfügbarkeit prüfen

Questions on Vancomycin Dosing

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1777-e1778

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Pharmacotherapy, 2009-11, Vol.29 (11), p.1275-1279

2009

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.5841-5848

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical experience with daptomycin: bacteraemia and endocarditis

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (suppl-3), p.iii35-iii39

Levine, Donald P

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(286)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(242)
Life Sciences & Biomedicine
(223)
Humans
(196)
Male
(137)
Female
(133)
Middle Aged
(89)
Adult
(83)
Infectious Diseases
(83)
Biological And Medical Sciences
(81)
Medical Sciences
(76)
Microbiology
(65)
Aged
(57)
Immunology
(47)
Treatment Outcome
(37)
Pharmacology. Drug Treatments
(35)
Child, Preschool
(34)
Anti-Bacterial Agents - Therapeutic Use
(33)
Pharmacology & Pharmacy
(30)
General & Internal Medicine
(29)
Infant
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vancomycin: A History

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections

Daptomycin in the Treatment of Patients with Infective Endocarditis: Experience from a Registry

Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia

Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis

Outcome of patients with injection drug use–associated endocarditis admitted to an intensive care unit

Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus

Impact of Delayed Therapy in Serious Bacterial Infections: Role of Technology and the Clinician at the Bedside

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Questions on Vancomycin Dosing

Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Clinical experience with daptomycin: bacteraemia and endocarditis

Suchergebnisse filtern